Alberta Investment Management Corp (AIMCo)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,982	Closed	-$787K	–	1223
2023 Q1	$787K	Hold	20,982	–	–	0.01%	827
2022 Q4	$588K	Buy	20,982 +4,918	+31%	+$143K	0.01%	898
2022 Q3	$451K	Buy	+16,064	New	+$524K	﹤0.01%	1091
2022 Q1	–	Sell	-52,164	Closed	-$1.22M	–	1293
2021 Q4	$1.22M	Buy	+52,164	New	+$1.07M	0.01%	705
2019 Q4	–	Sell	-22,800	Closed	-$452K	–	914
2019 Q3	$452K	Buy	+22,800	New	+$475K	﹤0.01%	766

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s AMPH Position: Q2 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2023, closing a stake of 20,982 shares — an estimated $787K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in AMPH in Q3 2019 and held it in 5 quarters. The position peaked at $1.22M in Q4 2021. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Amphastar Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 20,982 Amphastar Pharmaceuticals shares in Q2 2023, an estimated $787K.
Alberta Investment Management Corp (AIMCo) first reported a position in Amphastar Pharmaceuticals in Q3 2019 and held it in 5 quarters.
Alberta Investment Management Corp (AIMCo)'s Amphastar Pharmaceuticals position peaked at $1.22M in Q4 2021.
245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2023, filed 14 Aug 2023.